Alzheimer Disease – Effect of Continuous Intracerebroventricular Treatment with GM1 Ganglioside and a Systematic Activation Programme

Publisher： Karger

E-ISSN： 1421-9824|14|3|128-136

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.14, Iss.3, 2002-09, pp. : 128-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Altered Distribution of the Gangliosides GM1 and GM2 in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 33, Iss. 2-3, 2012-05 ,pp. : 174-188

Karger

Access to resources Recommend Favorite

Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 5, 1998-08 ,pp. : 246-257

Karger

Access to resources Recommend Favorite

Does exogenous GM1 ganglioside enhance the effects of electrical stimulation in ameliorating degeneration after neonatal deafness?

By Osofsky M.R.   Moore C.M.   Leake P.A.  

Hearing Research, Vol. 159, Iss. 1, 2001-09 ,pp. : 23-35

Elsevier

Access to resources Recommend Favorite

Treatment of Alzheimer’s Disease with Clioquinol

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 6, 2001-10 ,pp. : 408-414

Karger

Access to resources Recommend Favorite

Rivastigmine in the Treatment of Alzheimer’s Disease

By  

European Neurology, Vol. 46, Iss. 2, 2001-08 ,pp. : 110-110

Karger

Access to resources Recommend Favorite